Research work · 2013
Epidural administration of oxycodone
Merja Kokki, Pyry A. J. Välitalo, M. Kuusisto, Veli‐Pekka Ranta, Ari Tolonen, Hannu J. Kokki
European Journal of Anaesthesiology
Abstract
Background and Goal of Study: Parenteral and peroral oxycodone are increasingly used, but only two studies report epidural administration and with conflicting results. In one study, no advantage of epidural oxycodone compared to intravenous (IV) administration was noted (1), while another concluded that epidural oxycodone had an analgesic potency of 2:1 compared with epidural morphine and ocycodone was associated with less adverse effects (2). The goal here was to evaluate central nervous system penetration and opioid sparing efficacy of oxycodone after epidural and IV dosing. Materials and Methods: The study was randomised double-blinded and double-dummy with parallel groups. The local ethics committee and the national authority body approved the study design. 24 women presenting for elective gynaecological surgery with epidural analgesia were recruited. A low thoracic epidural catheter and lumbar spinal catheter were placed before anaesthesia for test drug administration and for cerebrospinal fluid (CSF) sampling. Patients were given oxycodone 0.1 mg/kg up to 10 mg either into the epidural (n=12) or IV (n=12) catheter at the end of surgery. Normal saline was used as a placebo. Blood and CSF sampling were performed at 2, 5, 15, 30, 45 min and 1, 2, 3, 4, 8, and 24 h after oxycodone administration for oxycodone assay. Results and Discussion: Oxycodone permeated readily into CSF after epidural administration, the highest oxycodone CSF concentration (Cmax) 8960 ng/ml was achieved at 35 min that was 300-times higher and 30 minutes earlier than after IV dose, Cmax 28 ng/ml and Tmax 65 min, respectively. Seven out of 12 patients in the epidural-group and all in the IV-group needed fentanyl for rescue analgesia during the first 4 hours after surgery. Adverse effects were similar in the two groups. The present study shows that when given epidurally, oxycodone readily diffuses into CSF and analgesic efficacy is better than achieved with a same dose given IV. Further studies are warranted to evaluate optimal dose and safety of epidural oxycodone in larger patient population. Conclusion(s): After epidural dosing oxycodone enters CSF readily, decreases the need for rescue analgesia and could, thus be a feasible option for acute pain management in patients with epidural catheter in place.